APY Therapeutics
PrivateLast Round
Grant
Jul 9, 2025
Total Funding Raised
$51,600
Company Overview
APY Therapeutics operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Grant round in July 2025.
APY Therapeutics is a biotechnology company developing novel first-in-class arylmyxopyronin-based treatments for drug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APY Therapeutics Comparables
Compare APY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 86% | |
| Kinvard Bio | 84% | |
| Macrolide Pharmaceuticals | 79% |
For institutional investors. Book with your work email.
APY Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2025 | ||||
| Grant | Jun 2, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
APY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors grew 74% MoM.
- Mar 2, 2026
Monthly visitors increased 52% MoM.
For institutional investors. Book with your work email.
APY Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about APY Therapeutics's valuation, stock price, and market status.
Is APY Therapeutics a public or private company?
APY Therapeutics is a private company.
What is the current stock price of APY Therapeutics?
APY Therapeutics is a private company, so its shares have no public market price. Caplight tracks APY Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is APY Therapeutics worth (valuation)?
Valuation information for APY Therapeutics is not publicly available.
Can I buy APY Therapeutics stock?
APY Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was APY Therapeutics's last funding round?
APY Therapeutics's most recent funding round was Grant on July 9, 2025.
Who are the main investors in APY Therapeutics?
Key investors in APY Therapeutics include New Jersey Commission on Science, Innovation and Technology, INCATE.
Will APY Therapeutics IPO soon?
No public IPO plans have been announced for APY Therapeutics.
How can I track APY Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in APY Therapeutics's shares on secondary markets.